AccessPak for HIV PEP Expanded with Kaletra and Bone toxicity
Result of checking the interaction of drug AccessPak for HIV PEP Expanded with Kaletra and disease Bone toxicity for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Osteomalacia and reduced bone mineral density have been reported in animal toxicology studies involving tenofovir exposures 6- to 12-fold those observed in humans. The mechanism of bone toxicity has not been established, and it is not known if long-term use of tenofovir disoproxil fumarate will cause bone abnormalities in humans.
- "Product Information. Viread (tenofovir)." Gilead Sciences, Foster City, CA.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand Name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
AccessPak for HIV PEP Expanded with Kaletra - toksyczność kości 
AccessPak for HIV PEP Expanded with Kaletra - toxicidade óssea 
AccessPak for HIV PEP Expanded with Kaletra - ketoksikan tulang 
AccessPak for HIV PEP Expanded with Kaletra - toksisitas tulang 
AccessPak for HIV PEP Expanded with Kaletra - tossicità ossea 
AccessPak for HIV PEP Expanded with Kaletra - toxicité osseuse 
AccessPak for HIV PEP Expanded with Kaletra - Knochentoxizität 
AccessPak for HIV PEP Expanded with Kaletra - toxicidad ósea 
AccessPak for HIV PEP Expanded with Kaletra - костная токсичность 
AccessPak for HIV PEP Expanded with Kaletra - kemik toksisitesi 
AccessPak for HIV PEP Expanded with Kaletra - سمية العظام 
AccessPak for HIV PEP Expanded with Kaletra - 骨毒性